Evidence map›Paper›PMID 26816652›Full record

ArticleRegenerative biomaterials2016

Properties of carbon nanotube-dispersed Sr-hydroxyapatite injectable material for bone defects.

M G Raucci, M Alvarez-Perez, D Giugliano, S Zeppetelli, L Ambrosio

Open access · goldAbstract read
In one paragraph

Article in Regenerative biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

M G RaucciInstitute of Polymers, Composites and Biomaterials, National Research Council of Italy, Mostra D'oltremare Pad.20 - Viale Kennedy 54, Naples 80125, Italy;
M Alvarez-PerezTissue Bioengineering Laboratory, DEPeI, Faculty of Dentistry, National Autonomous University of Mexico, Mexico DF 04510, Mexico;
D GiuglianoInstitute of Polymers, Composites and Biomaterials, National Research Council of Italy, Mostra D'oltremare Pad.20 - Viale Kennedy 54, Naples 80125, Italy;
S ZeppetelliInstitute of Polymers, Composites and Biomaterials, National Research Council of Italy, Mostra D'oltremare Pad.20 - Viale Kennedy 54, Naples 80125, Italy;
L AmbrosioInstitute of Polymers, Composites and Biomaterials, National Research Council of Italy, Mostra D'oltremare Pad.20 - Viale Kennedy 54, Naples 80125, Italy;; Department of Chemical Sciences and Materials Technology, National Research Council of Italy, (DSCTM-CNR), P.Le Aldo Moro 7, Rome 00185, Italy.
Institute of Polymers, Composites and Biomaterials · ITNational Research Council · ITUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study concerns the synthesis of gel materials based on carbon nanotubes dispersed strontium-modified hydroxyapatite (Sr-HA) at different compositions obtained by sol-gel technology and their influence on human-bone-marrow-derived mesenchymal stem cells. Furthermore, an evaluation of the influence of nanotubes and Strontium on physico-chemical, morphological, rheological and biological properties of hydroxyapatite gel was also performed. Morphological analysis (scanning electron microscopy) shows a homogeneous distribution of modified nanotubes in the ceramic matrix improving the bioactive properties of materials. The biological investigations proved that Sr-HA/carbon nanotube gel containing 0-20 mol (%) of Sr showed no toxic effect and promote the expression of early and late markers of osteogenic differentiation in cell culture performed in basal medium without osteogenic factors. Finally, the SrHA/carbon nanotube gels could have a good potential application as filler in bone repair and regeneration and may be used in the osteoporotic disease treatment.

Indexed as

bioceramicsbiomaterial-cell interactionbone tissue engineeringnanobiomaterialssol-gel tecnology

Identifiers

PMID26816652
PMCPMC4723275
OpenAlexW2421716201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.